Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2014

Open Access 01-12-2014 | Research article

Comparison of two alternative study designs in assessment of medicines utilisation in neonates

Authors: Georgi Nellis, Irja Lutsar, Heili Varendi, Karolin Toompere, Mark A Turner, Jennifer Duncan, Tuuli Metsvaht

Published in: BMC Medical Research Methodology | Issue 1/2014

Login to get access

Abstract

Background

Estimates of prevalence are known to be affected by the design of cross-sectional studies. A pan-European study provided an opportunity to compare the effect of two cross-sectional study designs on estimates of medicines use.

Methods

A Service evaluation survey (SES) and a web-based point-prevalence study (PPS) were conducted as part of a European study of neonatal exposure to excipients. Neonatal units from all European Union countries plus Iceland, Norway, Switzerland and Serbia were invited to participate. All medicines prescribed to neonates were recorded during three-day and one-day study periods in the SES and PPS, respectively. In the PPS individual demographic and prescription data were also collected.
To compare the probabilities that a particular medicine would be reported by each study multilevel mixed effects logistic regression models with crossed random effects were applied. The relationship between medicines exposure at the unit and individual levels in the PPS data was assessed using polynomial regression with square root transformation.

Results

Of 31 invited countries 20 and 21 with 115 and 89 units joined the SES and PPS, respectively. Out of 5,572,859 live births in invited countries in 2010 a higher proportion was covered by units participating in the SES compared to the PPS (11% vs 6%, respectively; OR 1.89; 95% CI 1.87-1.89). A greater number of active pharmaceutical ingredients (API), manufacturers and trade names were registered in the SES compared to the PPS. High correlation between the two studies in frequency of use for each specified API was seen (R2 = 0.86). The average probability of a department to use a given API was greater in the SES compared to the PPS (OR 2.36; 95% CI 2.05-2.73) with higher frequency of use and longer average duration of prescription further increasing the difference. The polynomial regression model described the correlation between APIs exposure on unit and individual level well (R2 = 0.93).

Conclusion

The simple data structure and longer study period of the SES resulted in improved recruitment and higher likelihood of capture for a given API. The frequency of use at the unit level appears a good surrogate of individual exposure rates.
Appendix
Available only for authorised users
Literature
1.
go back to reference Roberts JA, De Waele JJ, Dimopoulos G, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J: DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic. BMC Infect Dis. 2012, 12: 152-CrossRefPubMedPubMedCentral Roberts JA, De Waele JJ, Dimopoulos G, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J: DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic. BMC Infect Dis. 2012, 12: 152-CrossRefPubMedPubMedCentral
2.
go back to reference Zarb P, Amadeo B, Muller A, Drapier N, Vankerckhoven V, Davey P, Goossens H: Antifungal therapy in European hospitals: data from the ESAC point-prevalence surveys 2008 and 2009. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2012, 18: E389-E395. Zarb P, Amadeo B, Muller A, Drapier N, Vankerckhoven V, Davey P, Goossens H: Antifungal therapy in European hospitals: data from the ESAC point-prevalence surveys 2008 and 2009. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2012, 18: E389-E395.
3.
go back to reference Ingram PR, Seet JM, Budgeon CA, Murray R: Point-prevalence study of inappropriate antibiotic use at a tertiary Australian hospital. Intern Med J. 2012, 42: 719-721.CrossRefPubMed Ingram PR, Seet JM, Budgeon CA, Murray R: Point-prevalence study of inappropriate antibiotic use at a tertiary Australian hospital. Intern Med J. 2012, 42: 719-721.CrossRefPubMed
4.
go back to reference Amadeo B, Zarb P, Muller A, Drapier N, Vankerckhoven V, Rogues A-M, Davey P, Goossens H: European Surveillance of Antibiotic Consumption (ESAC) point prevalence survey 2008: paediatric antimicrobial prescribing in 32 hospitals of 21 European countries. J Antimicrob Chemother. 2010, 65: 2247-2252.CrossRefPubMed Amadeo B, Zarb P, Muller A, Drapier N, Vankerckhoven V, Rogues A-M, Davey P, Goossens H: European Surveillance of Antibiotic Consumption (ESAC) point prevalence survey 2008: paediatric antimicrobial prescribing in 32 hospitals of 21 European countries. J Antimicrob Chemother. 2010, 65: 2247-2252.CrossRefPubMed
5.
go back to reference Ansari F, Erntell M, Goossens H, Davey P: The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis an Off Publ Infect Dis Soc Am. 2009, 49: 1496-1504.CrossRef Ansari F, Erntell M, Goossens H, Davey P: The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis an Off Publ Infect Dis Soc Am. 2009, 49: 1496-1504.CrossRef
6.
go back to reference Zarb P, Amadeo B, Muller A, Drapier N, Vankerckhoven V, Davey P, Goossens H: Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009. J Antimicrob Chemother. 2011, 66: 443-449.CrossRefPubMed Zarb P, Amadeo B, Muller A, Drapier N, Vankerckhoven V, Davey P, Goossens H: Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009. J Antimicrob Chemother. 2011, 66: 443-449.CrossRefPubMed
7.
go back to reference Sequi M, Campi R, Clavenna A, Bonati M: Methods in pharmacoepidemiology: a review of statistical analyses and data reporting in pediatric drug utilization studies. Eur J Clin Pharmacol. 2013, 69: 599-604.CrossRefPubMed Sequi M, Campi R, Clavenna A, Bonati M: Methods in pharmacoepidemiology: a review of statistical analyses and data reporting in pediatric drug utilization studies. Eur J Clin Pharmacol. 2013, 69: 599-604.CrossRefPubMed
8.
go back to reference Zarb P, Goossens H: European Surveillance of Antimicrobial Consumption (ESAC). Drugs. 2011, 71: 745-755.CrossRefPubMed Zarb P, Goossens H: European Surveillance of Antimicrobial Consumption (ESAC). Drugs. 2011, 71: 745-755.CrossRefPubMed
9.
go back to reference Lass J, Käär R, Jõgi K, Varendi H, Metsvaht T, Lutsar I: Drug utilisation pattern and off-label use of medicines in Estonian neonatal units. Eur J Clin Pharmacol. 2011, 67: 1263-1271.CrossRefPubMed Lass J, Käär R, Jõgi K, Varendi H, Metsvaht T, Lutsar I: Drug utilisation pattern and off-label use of medicines in Estonian neonatal units. Eur J Clin Pharmacol. 2011, 67: 1263-1271.CrossRefPubMed
10.
go back to reference Schmidt W-P, Arnold BF, Boisson S, Genser B, Luby SP, Barreto ML, Clasen T, Cairncross S: Epidemiological methods in diarrhoea studies–an update. Int J Epidemiol. 2011, 40: 1678-1692.CrossRefPubMedPubMedCentral Schmidt W-P, Arnold BF, Boisson S, Genser B, Luby SP, Barreto ML, Clasen T, Cairncross S: Epidemiological methods in diarrhoea studies–an update. Int J Epidemiol. 2011, 40: 1678-1692.CrossRefPubMedPubMedCentral
11.
go back to reference Turner M: European Study of Neonatal Exposure to Excipients (ESNEE). Infant. 2011, 7: 1-4. Turner M: European Study of Neonatal Exposure to Excipients (ESNEE). Infant. 2011, 7: 1-4.
14.
go back to reference Labenne M, Michaut F, Gouyon B, Ferdynus C, Gouyon J-B: A population-based observational study of restrictive guidelines for antibiotic therapy in early-onset neonatal infections. Pediatr Infect Dis J. 2007, 26: 593-599.CrossRefPubMed Labenne M, Michaut F, Gouyon B, Ferdynus C, Gouyon J-B: A population-based observational study of restrictive guidelines for antibiotic therapy in early-onset neonatal infections. Pediatr Infect Dis J. 2007, 26: 593-599.CrossRefPubMed
15.
go back to reference Dani C, Corsini I, Piergentili L, Bertini G, Pratesi S, Rubaltelli FF: Neonatal morbidity in late preterm and term infants in the nursery of a tertiary hospital. Acta Paediatr (Oslo, Norw 1992). 2009, 98: 1841-1843.CrossRef Dani C, Corsini I, Piergentili L, Bertini G, Pratesi S, Rubaltelli FF: Neonatal morbidity in late preterm and term infants in the nursery of a tertiary hospital. Acta Paediatr (Oslo, Norw 1992). 2009, 98: 1841-1843.CrossRef
16.
go back to reference Tracy SK, Tracy MB, Sullivan E: Admission of term infants to neonatal intensive care: a population-based study. Birth. 2007, 34: 301-307.CrossRefPubMed Tracy SK, Tracy MB, Sullivan E: Admission of term infants to neonatal intensive care: a population-based study. Birth. 2007, 34: 301-307.CrossRefPubMed
17.
go back to reference Schiariti V, Klassen AF, Houbé JS, Synnes A, Lisonkova S, Lee SK: Perinatal characteristics and parents’ perspective of health status of NICU graduates born at term. J Perinatol Off J Calif Perinat Assoc. 2008, 28: 368-376.CrossRef Schiariti V, Klassen AF, Houbé JS, Synnes A, Lisonkova S, Lee SK: Perinatal characteristics and parents’ perspective of health status of NICU graduates born at term. J Perinatol Off J Calif Perinat Assoc. 2008, 28: 368-376.CrossRef
18.
go back to reference Losacco V, Cuttini M, Greisen G, Haumont D, Pallás-Alonso CR, Pierrat V, Warren I, Smit BJ, Westrup B, Sizun J: Heel blood sampling in European neonatal intensive care units: compliance with pain management guidelines. Arch Dis Child Fetal Neonatal Ed. 2011, 96: F65-F68.PubMed Losacco V, Cuttini M, Greisen G, Haumont D, Pallás-Alonso CR, Pierrat V, Warren I, Smit BJ, Westrup B, Sizun J: Heel blood sampling in European neonatal intensive care units: compliance with pain management guidelines. Arch Dis Child Fetal Neonatal Ed. 2011, 96: F65-F68.PubMed
19.
go back to reference Zeitlin J, Papiernik E, Bréart G: Regionalization of perinatal care in Europe. Semin Neonatol SN. 2004, 9: 99-110.CrossRefPubMed Zeitlin J, Papiernik E, Bréart G: Regionalization of perinatal care in Europe. Semin Neonatol SN. 2004, 9: 99-110.CrossRefPubMed
20.
go back to reference Greisen G, Mirante N, Haumont D, Pierrat V, Pallás-Alonso CR, Warren I, Smit BJ, Westrup B, Sizun J, Maraschini A, Cuttini M: Parents, siblings and grandparents in the Neonatal Intensive Care Unit. A survey of policies in eight European countries. Acta Paediatr (Oslo, Norw 1992). 2009, 98: 1744-1750.CrossRef Greisen G, Mirante N, Haumont D, Pierrat V, Pallás-Alonso CR, Warren I, Smit BJ, Westrup B, Sizun J, Maraschini A, Cuttini M: Parents, siblings and grandparents in the Neonatal Intensive Care Unit. A survey of policies in eight European countries. Acta Paediatr (Oslo, Norw 1992). 2009, 98: 1744-1750.CrossRef
21.
go back to reference Cuttini M, Rebagliato M, Bortoli P, Hansen G, de Leeuw R, Lenoir S, Persson J, Reid M, Schroell M, de Vonderweid U, Kaminski M, Lenard H, Orzalesi M, Saracci R: Parental visiting, communication, and participation in ethical decisions: a comparison of neonatal unit policies in Europe. Arch Dis Child Fetal Neonatal Ed. 1999, 81: F84-F91.CrossRefPubMedPubMedCentral Cuttini M, Rebagliato M, Bortoli P, Hansen G, de Leeuw R, Lenoir S, Persson J, Reid M, Schroell M, de Vonderweid U, Kaminski M, Lenard H, Orzalesi M, Saracci R: Parental visiting, communication, and participation in ethical decisions: a comparison of neonatal unit policies in Europe. Arch Dis Child Fetal Neonatal Ed. 1999, 81: F84-F91.CrossRefPubMedPubMedCentral
24.
go back to reference Modi N: Categories of Care 2011. British association of perinatal medicine. 2011, London, UK Modi N: Categories of Care 2011. British association of perinatal medicine. 2011, London, UK
26.
go back to reference Raudenbush SW: A crossed random effects model for unbalanced data with applications in cross-sectional and longitudinal research. J Educ Stat. 1993, 18: 321-349.CrossRef Raudenbush SW: A crossed random effects model for unbalanced data with applications in cross-sectional and longitudinal research. J Educ Stat. 1993, 18: 321-349.CrossRef
28.
go back to reference Zou GY, Donner A: Extension of the modified Poisson regression model to prospective studies with correlated binary data. Stat Methods Med Res. 2013, 22: 661-670.CrossRefPubMed Zou GY, Donner A: Extension of the modified Poisson regression model to prospective studies with correlated binary data. Stat Methods Med Res. 2013, 22: 661-670.CrossRefPubMed
29.
go back to reference Neubert A, Lukas K, Leis T, Dormann H, Brune K, Rascher W: Drug utilisation on a preterm and neonatal intensive care unit in Germany: a prospective, cohort-based analysis. Eur J Clin Pharmacol. 2010, 66: 87-95.CrossRefPubMed Neubert A, Lukas K, Leis T, Dormann H, Brune K, Rascher W: Drug utilisation on a preterm and neonatal intensive care unit in Germany: a prospective, cohort-based analysis. Eur J Clin Pharmacol. 2010, 66: 87-95.CrossRefPubMed
30.
go back to reference Turner MA, Duncan J, Shah U, Metsvaht T, Varendi H, Nellis G, Lutsar I, Yakkundi S, McElnay J, Pandya H, Mulla H, Vaconsin P, Storme T, Rieutord A, Nunn AJ: Risk assessment of neonatal excipient exposure: Lessons from food safety and other areas. Adv Drug Deliv Rev. 2014, 73C: 89-101.CrossRef Turner MA, Duncan J, Shah U, Metsvaht T, Varendi H, Nellis G, Lutsar I, Yakkundi S, McElnay J, Pandya H, Mulla H, Vaconsin P, Storme T, Rieutord A, Nunn AJ: Risk assessment of neonatal excipient exposure: Lessons from food safety and other areas. Adv Drug Deliv Rev. 2014, 73C: 89-101.CrossRef
31.
go back to reference Verhamme K, Sturkenboom M: Study designs in paediatric pharmacoepidemiology. Eur J Clin Pharmacol. 2011, 67 (Suppl 1): 67-74.CrossRefPubMed Verhamme K, Sturkenboom M: Study designs in paediatric pharmacoepidemiology. Eur J Clin Pharmacol. 2011, 67 (Suppl 1): 67-74.CrossRefPubMed
32.
go back to reference White HL, Macpherson AK: Capturing paediatric injury in Ontario: differences in injury incidence using self-reported survey and health service utilisation data. Inj Prev. 2012, 18: 33-37.CrossRefPubMed White HL, Macpherson AK: Capturing paediatric injury in Ontario: differences in injury incidence using self-reported survey and health service utilisation data. Inj Prev. 2012, 18: 33-37.CrossRefPubMed
33.
go back to reference Melo MCND, Taddei JAD AC, Diniz-Santos DR, May DS, Carneiro NB, Silva LR: Incidence of diarrhea: poor parental recall ability. Brazilian J Infect Dis an Off Publ Brazilian Soc Infect Dis. 2007, 11: 571-579.CrossRef Melo MCND, Taddei JAD AC, Diniz-Santos DR, May DS, Carneiro NB, Silva LR: Incidence of diarrhea: poor parental recall ability. Brazilian J Infect Dis an Off Publ Brazilian Soc Infect Dis. 2007, 11: 571-579.CrossRef
34.
go back to reference Alam N, Henry FJ, Rahaman M: Reporting errors in one-week diarrhoea recall surveys: experience from a prospective study in rural Bangladesh. Int J Epidemiol. 1989, 18: 697-700.CrossRefPubMed Alam N, Henry FJ, Rahaman M: Reporting errors in one-week diarrhoea recall surveys: experience from a prospective study in rural Bangladesh. Int J Epidemiol. 1989, 18: 697-700.CrossRefPubMed
35.
go back to reference Knottnerus JA, Tugwell P: Ongoing progress in research on drug exposure and adverse events. J Clin Epidemiol. 2012, 65: 1029-1030.CrossRefPubMed Knottnerus JA, Tugwell P: Ongoing progress in research on drug exposure and adverse events. J Clin Epidemiol. 2012, 65: 1029-1030.CrossRefPubMed
36.
go back to reference Gagnon JP, Rindress D: Pharmacoeconomics: Identifying The Issues. 1998, USA: International Society for Pharmacoeconomics and Outcomes Research Gagnon JP, Rindress D: Pharmacoeconomics: Identifying The Issues. 1998, USA: International Society for Pharmacoeconomics and Outcomes Research
37.
go back to reference LeBel M, Ferron L, Masson M, Pichette J, Carrier C: Benzyl alcohol metabolism and elimination in neonates. Dev Pharmacol Ther. 1988, 11: 347-356.PubMed LeBel M, Ferron L, Masson M, Pichette J, Carrier C: Benzyl alcohol metabolism and elimination in neonates. Dev Pharmacol Ther. 1988, 11: 347-356.PubMed
38.
go back to reference Hiller JL, Benda GI, Rahatzad M, Allen JR, David H, Carlson CV, Reynolds JW, Culver DH, Carison CV: Benzyl alcohol toxicity: impact on mortality and intraventricular hemorrhage among very low birth weight infants the online version of this article, along with updated information and services, is located on the world wide web at: benzyl alcohol toxic. Pediatrics. 1986, 77: 500-506.PubMed Hiller JL, Benda GI, Rahatzad M, Allen JR, David H, Carlson CV, Reynolds JW, Culver DH, Carison CV: Benzyl alcohol toxicity: impact on mortality and intraventricular hemorrhage among very low birth weight infants the online version of this article, along with updated information and services, is located on the world wide web at: benzyl alcohol toxic. Pediatrics. 1986, 77: 500-506.PubMed
39.
go back to reference Warrier I, Du W, Natarajan G, Salari V, Aranda J: Patterns of drug utilization in a neonatal intensive care unit. J Clin Pharmacol. 2006, 46: 449-455.CrossRefPubMed Warrier I, Du W, Natarajan G, Salari V, Aranda J: Patterns of drug utilization in a neonatal intensive care unit. J Clin Pharmacol. 2006, 46: 449-455.CrossRefPubMed
40.
go back to reference Clark RH, Bloom BT, Spitzer AR, Gerstmann DR: Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics. 2006, 117: 1979-1987.CrossRefPubMed Clark RH, Bloom BT, Spitzer AR, Gerstmann DR: Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics. 2006, 117: 1979-1987.CrossRefPubMed
41.
go back to reference Zarb P, Coignard B, Griskeviciene J, Muller A, Vankerckhoven V, Weist K, Goossens M, Vaerenberg S, Hopkins S, Catry B, Monnet D, Goossens H, Suetens C: The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill Bull Eur sur les Mal Transm = Eur Commun Dis Bull. 2012, 17 (46): pii=20316 Zarb P, Coignard B, Griskeviciene J, Muller A, Vankerckhoven V, Weist K, Goossens M, Vaerenberg S, Hopkins S, Catry B, Monnet D, Goossens H, Suetens C: The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill Bull Eur sur les Mal Transm = Eur Commun Dis Bull. 2012, 17 (46): pii=20316
Metadata
Title
Comparison of two alternative study designs in assessment of medicines utilisation in neonates
Authors
Georgi Nellis
Irja Lutsar
Heili Varendi
Karolin Toompere
Mark A Turner
Jennifer Duncan
Tuuli Metsvaht
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2014
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/1471-2288-14-89

Other articles of this Issue 1/2014

BMC Medical Research Methodology 1/2014 Go to the issue